|
MREO Mereo BioPharma Group plc - ADR 1719714 |
| Balance Sheet |
|
Current Assets
|
$40,034,000.00 |
|
Assets
|
$80,638,000.00 |
|
Current Liabilities
|
$6,177,000.00 |
|
Liabilities
|
$22,893,000.00 |
|
Equity
|
$34,054,000.00 |
|
Shares Out
|
798093044.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,312,000.00 |
|
Investing Cash Flow
|
$-300,000.00 |
| Market Analysis |
Market Cap
|
$255,389,774.08 |
|
Price
|
$0.34 |
|
BVPS
|
0.04 |
|
PB
|
8.00 |
|
EPS
|
-0.01 |
|
PS
|
526.74 |
|
FCF
|
$-4,312,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:39 |
|
| Apr |
May |
Jun |
| 2026-03-19 |
|
|
|
2026-05-12 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MREO documents filed with the SEC.
MREO Filings
Clear
